Kotryna Seip

Nydalen, 0424, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis.

Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis.

Journal: Journal of translational medicine
Published: March 07, 2025

Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.

Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.

Journal: Breast cancer research : BCR
Published: March 03, 2025

The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy.

The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy.

Journal: British journal of cancer
Published: May 10, 2024

AXL inhibition improves BRAF-targeted treatment in melanoma.

AXL inhibition improves BRAF-targeted treatment in melanoma.

Journal: Scientific reports
Published: July 29, 2021

EMT-Derived Alterations in Glutamine Metabolism Sensitize Mesenchymal Breast Cells to mTOR Inhibition.

EMT-Derived Alterations in Glutamine Metabolism Sensitize Mesenchymal Breast Cells to mTOR Inhibition.

Journal: Molecular cancer research : MCR
Published: November 04, 2020

Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen.

Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen.

Journal: Molecular oncology
Published: August 16, 2020

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells.

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells.

Journal: Scientific reports
Published: April 08, 2020

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.

Journal: Scientific reports
Published: December 19, 2018

Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment.

Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment.

Journal: Cancer letters
Published: July 11, 2018

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors.

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors.

Journal: Oncotarget
Published: October 30, 2015
Showing 1-10 of 10

Last Updated: 09/26/2026